Results Healthcare   |   Results International

CROs and CMOs

We work with CROs and CMOs in organisation asset restructuring and building core divisions through M&A activity.

CROs and CMOs

Clinical/contract research organisations (CROs) in particular are among the strongest growth sectors of the pharmaceutical industry, with many firms across the sector experiencing double- digit annual growth. This growth is driven by the trend for increased outsourcing by pharmaceutical and biotechnology companies looking to shift fixed to variable costs and access specialist capabilities not found in-house, and an overall increase in biopharmaceutical R&D spending. CROs have also become one of the most active sectors for M&A, with larger players consolidating to achieve critical mass, as well as completing bolt-on acquisitions to offer a more comprehensive service offering.

Our team has a strong track-record in successful CRO transactions.

26 Jan 2017

Pharma & Biotech 2017 – Review of Outsourced Manufacturing

This report provides an in-depth review of the pharmaceutical outsourced manufacturing sector, including latest data on the pharmaceutical and CMO…

02 Nov 2017

The CVS-Aetna Deal: A Transaction Spurred by Amazon

At last week’s Connected Health Conference, we had the opportunity to talk to over 50 companies, including health insurers, about…


Weekly Public Healthcare Sector Analysis, News, Blogs & White Papers

View our insights

Connect with us

Follow Results Healthcare on Twitter Follow Results Healthcare on LinkedIn

Your Nearest Office